Concepts (298)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Rectal Neoplasms | 24 | 2025 | 1183 | 2.980 |
Why?
|
Colonic Neoplasms | 20 | 2024 | 2541 | 1.910 |
Why?
|
Colectomy | 17 | 2024 | 696 | 1.810 |
Why?
|
Colorectal Surgery | 4 | 2022 | 125 | 1.280 |
Why?
|
Digestive System Surgical Procedures | 4 | 2021 | 583 | 1.020 |
Why?
|
Neoadjuvant Therapy | 11 | 2025 | 2907 | 0.990 |
Why?
|
Colorectal Neoplasms | 15 | 2024 | 6974 | 0.890 |
Why?
|
Neoplasm Staging | 29 | 2024 | 11244 | 0.880 |
Why?
|
Neoplasm Recurrence, Local | 10 | 2023 | 9419 | 0.850 |
Why?
|
Adenocarcinoma | 10 | 2025 | 6395 | 0.780 |
Why?
|
Anus Neoplasms | 3 | 2020 | 336 | 0.770 |
Why?
|
Rectum | 9 | 2024 | 900 | 0.750 |
Why?
|
Colonic Pouches | 5 | 2020 | 122 | 0.590 |
Why?
|
Postoperative Complications | 23 | 2024 | 15832 | 0.560 |
Why?
|
Colitis, Ulcerative | 8 | 2023 | 1926 | 0.550 |
Why?
|
Diverticulitis, Colonic | 4 | 2024 | 139 | 0.520 |
Why?
|
Patients | 1 | 2021 | 908 | 0.460 |
Why?
|
Salvage Therapy | 1 | 2020 | 1273 | 0.430 |
Why?
|
Retrospective Studies | 51 | 2025 | 81762 | 0.400 |
Why?
|
Proctoscopy | 1 | 2012 | 40 | 0.390 |
Why?
|
Length of Stay | 7 | 2022 | 6498 | 0.390 |
Why?
|
Anastomotic Leak | 2 | 2024 | 170 | 0.380 |
Why?
|
Colon | 6 | 2024 | 1801 | 0.380 |
Why?
|
Aged | 54 | 2025 | 171504 | 0.370 |
Why?
|
Venous Thromboembolism | 3 | 2021 | 1883 | 0.350 |
Why?
|
Abdominal Abscess | 2 | 2022 | 153 | 0.340 |
Why?
|
Inflammatory Bowel Diseases | 3 | 2023 | 2442 | 0.330 |
Why?
|
Neoplasm Invasiveness | 8 | 2022 | 3620 | 0.330 |
Why?
|
Proctocolectomy, Restorative | 3 | 2021 | 191 | 0.330 |
Why?
|
Independent Living | 2 | 2024 | 584 | 0.320 |
Why?
|
Fellowships and Scholarships | 1 | 2017 | 1135 | 0.310 |
Why?
|
Neoplasms, Second Primary | 3 | 2023 | 1061 | 0.310 |
Why?
|
Transcranial Magnetic Stimulation | 3 | 2024 | 1490 | 0.300 |
Why?
|
Survivors | 2 | 2016 | 2381 | 0.300 |
Why?
|
Middle Aged | 53 | 2025 | 223492 | 0.290 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2020 | 4058 | 0.290 |
Why?
|
Disease-Free Survival | 11 | 2022 | 6847 | 0.280 |
Why?
|
Anastomosis, Surgical | 4 | 2024 | 991 | 0.280 |
Why?
|
Colostomy | 2 | 2017 | 106 | 0.270 |
Why?
|
Microsatellite Instability | 2 | 2021 | 726 | 0.270 |
Why?
|
Hospital Mortality | 3 | 2019 | 5349 | 0.260 |
Why?
|
Microsurgery | 1 | 2012 | 800 | 0.260 |
Why?
|
Male | 64 | 2025 | 364719 | 0.250 |
Why?
|
Neoplasm, Residual | 3 | 2021 | 1015 | 0.250 |
Why?
|
Humans | 95 | 2025 | 768166 | 0.250 |
Why?
|
Geriatrics | 1 | 2010 | 394 | 0.250 |
Why?
|
Anticoagulants | 2 | 2021 | 4852 | 0.240 |
Why?
|
Hospitals | 2 | 2020 | 3886 | 0.240 |
Why?
|
Female | 63 | 2025 | 397192 | 0.230 |
Why?
|
Survival Rate | 12 | 2024 | 12840 | 0.220 |
Why?
|
Methoxyhydroxyphenylglycol | 1 | 2023 | 93 | 0.220 |
Why?
|
Databases, Factual | 6 | 2024 | 8080 | 0.210 |
Why?
|
Population Surveillance | 2 | 2010 | 2596 | 0.210 |
Why?
|
Hospices | 2 | 2023 | 245 | 0.210 |
Why?
|
Current Procedural Terminology | 1 | 2024 | 101 | 0.210 |
Why?
|
General Surgery | 5 | 2019 | 1720 | 0.210 |
Why?
|
Specialties, Surgical | 2 | 2017 | 391 | 0.200 |
Why?
|
Lymphopenia | 1 | 2025 | 300 | 0.200 |
Why?
|
Crohn Disease | 3 | 2019 | 2295 | 0.200 |
Why?
|
Hypoalbuminemia | 1 | 2023 | 90 | 0.200 |
Why?
|
Quality of Life | 4 | 2024 | 13490 | 0.200 |
Why?
|
Intestinal Perforation | 2 | 2021 | 254 | 0.200 |
Why?
|
Laparoscopy | 4 | 2022 | 2041 | 0.190 |
Why?
|
Combined Modality Therapy | 4 | 2020 | 8542 | 0.180 |
Why?
|
Hospitalization | 1 | 2021 | 10840 | 0.180 |
Why?
|
Carcinoma, Signet Ring Cell | 1 | 2021 | 81 | 0.180 |
Why?
|
Lymph Node Excision | 2 | 2024 | 1271 | 0.180 |
Why?
|
Hospital Records | 1 | 2020 | 93 | 0.180 |
Why?
|
Adult | 36 | 2025 | 223646 | 0.180 |
Why?
|
Registries | 6 | 2024 | 8375 | 0.170 |
Why?
|
Surgical Procedures, Operative | 3 | 2017 | 1932 | 0.170 |
Why?
|
Prognosis | 14 | 2025 | 30010 | 0.170 |
Why?
|
Oxytocin | 1 | 2024 | 404 | 0.170 |
Why?
|
Kaplan-Meier Estimate | 5 | 2025 | 6526 | 0.170 |
Why?
|
Aged, 80 and over | 15 | 2024 | 59629 | 0.170 |
Why?
|
Fecal Incontinence | 2 | 2020 | 246 | 0.160 |
Why?
|
Paget Disease, Extramammary | 1 | 2019 | 50 | 0.160 |
Why?
|
Genital Neoplasms, Male | 1 | 2019 | 68 | 0.160 |
Why?
|
Risk Adjustment | 2 | 2020 | 599 | 0.160 |
Why?
|
Enterocolitis, Pseudomembranous | 1 | 2021 | 264 | 0.160 |
Why?
|
Anti-Inflammatory Agents | 1 | 2008 | 1805 | 0.160 |
Why?
|
Strongylida Infections | 1 | 2018 | 48 | 0.150 |
Why?
|
Colon, Transverse | 1 | 2018 | 25 | 0.150 |
Why?
|
New York | 2 | 2019 | 882 | 0.150 |
Why?
|
Peripheral Nervous System Neoplasms | 1 | 2019 | 133 | 0.150 |
Why?
|
Defecation | 1 | 2020 | 191 | 0.150 |
Why?
|
Diverticulitis | 1 | 2021 | 187 | 0.150 |
Why?
|
Age Factors | 4 | 2024 | 18412 | 0.150 |
Why?
|
Internship and Residency | 2 | 2017 | 5953 | 0.150 |
Why?
|
International Classification of Diseases | 1 | 2024 | 937 | 0.150 |
Why?
|
Patient Education as Topic | 2 | 2018 | 2337 | 0.150 |
Why?
|
Lymphatic Metastasis | 3 | 2020 | 2914 | 0.150 |
Why?
|
Viscera | 1 | 2017 | 138 | 0.140 |
Why?
|
Intestinal Obstruction | 1 | 2020 | 433 | 0.130 |
Why?
|
Hospice Care | 1 | 2023 | 678 | 0.130 |
Why?
|
Receptors, Immunologic | 1 | 2023 | 1418 | 0.130 |
Why?
|
Frail Elderly | 1 | 2022 | 781 | 0.130 |
Why?
|
Cause of Death | 3 | 2024 | 3721 | 0.130 |
Why?
|
Anal Canal | 1 | 2019 | 376 | 0.130 |
Why?
|
Treatment Outcome | 19 | 2024 | 65371 | 0.130 |
Why?
|
Metformin | 1 | 2023 | 909 | 0.130 |
Why?
|
Patient Readmission | 3 | 2024 | 3288 | 0.120 |
Why?
|
Perioperative Care | 3 | 2024 | 1043 | 0.120 |
Why?
|
Travel | 1 | 2021 | 805 | 0.120 |
Why?
|
Risk Assessment | 6 | 2023 | 24315 | 0.120 |
Why?
|
Risk Factors | 14 | 2024 | 74944 | 0.120 |
Why?
|
Appendicitis | 1 | 2022 | 690 | 0.120 |
Why?
|
Medical Records | 1 | 2020 | 1410 | 0.120 |
Why?
|
Lymph Nodes | 4 | 2020 | 3474 | 0.120 |
Why?
|
Rectal Diseases | 1 | 2016 | 142 | 0.120 |
Why?
|
Antibodies, Monoclonal | 2 | 2009 | 9263 | 0.120 |
Why?
|
Colonic Diseases | 1 | 2016 | 204 | 0.120 |
Why?
|
Colitis | 1 | 2023 | 1242 | 0.120 |
Why?
|
Preoperative Period | 1 | 2017 | 565 | 0.120 |
Why?
|
Genital Neoplasms, Female | 1 | 2019 | 536 | 0.110 |
Why?
|
Cytomegalovirus Infections | 1 | 2021 | 837 | 0.110 |
Why?
|
Interleukin-1beta | 1 | 2020 | 1027 | 0.110 |
Why?
|
Emergencies | 2 | 2019 | 1221 | 0.110 |
Why?
|
Colonoscopy | 2 | 2019 | 1409 | 0.110 |
Why?
|
Constipation | 1 | 2019 | 570 | 0.110 |
Why?
|
Anemia | 1 | 2023 | 1514 | 0.110 |
Why?
|
Rural Population | 1 | 2024 | 2325 | 0.110 |
Why?
|
Feasibility Studies | 1 | 2024 | 5315 | 0.110 |
Why?
|
Blood Vessels | 1 | 2019 | 1110 | 0.110 |
Why?
|
Carcinoma in Situ | 1 | 2018 | 788 | 0.110 |
Why?
|
Geriatric Assessment | 1 | 2020 | 1422 | 0.100 |
Why?
|
Income | 1 | 2021 | 1878 | 0.100 |
Why?
|
Health Expenditures | 2 | 2022 | 2389 | 0.100 |
Why?
|
Follow-Up Studies | 9 | 2020 | 39348 | 0.100 |
Why?
|
Erythrocyte Transfusion | 1 | 2017 | 575 | 0.100 |
Why?
|
Prednisone | 1 | 2017 | 1567 | 0.100 |
Why?
|
Abdominal Pain | 1 | 2018 | 1070 | 0.100 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2019 | 1767 | 0.100 |
Why?
|
Terminal Care | 1 | 2023 | 1770 | 0.090 |
Why?
|
Proportional Hazards Models | 6 | 2022 | 12543 | 0.090 |
Why?
|
Cohort Studies | 9 | 2022 | 41754 | 0.090 |
Why?
|
Early Detection of Cancer | 2 | 2018 | 3239 | 0.090 |
Why?
|
Japan | 2 | 2024 | 1418 | 0.080 |
Why?
|
United States | 13 | 2024 | 73039 | 0.080 |
Why?
|
Preoperative Care | 1 | 2018 | 2258 | 0.080 |
Why?
|
Predictive Value of Tests | 2 | 2023 | 15454 | 0.080 |
Why?
|
Ileostomy | 2 | 2020 | 122 | 0.080 |
Why?
|
Health Status Disparities | 1 | 2021 | 1885 | 0.080 |
Why?
|
Comorbidity | 4 | 2022 | 10590 | 0.080 |
Why?
|
Quality Improvement | 3 | 2019 | 3857 | 0.080 |
Why?
|
Survival Analysis | 5 | 2019 | 10101 | 0.080 |
Why?
|
Developing Countries | 1 | 2021 | 2910 | 0.070 |
Why?
|
Chemotherapy, Adjuvant | 3 | 2021 | 3556 | 0.070 |
Why?
|
Surgical Wound Infection | 1 | 2017 | 1546 | 0.070 |
Why?
|
Abscess | 2 | 2022 | 606 | 0.070 |
Why?
|
Multivariate Analysis | 2 | 2019 | 12077 | 0.070 |
Why?
|
Time Factors | 6 | 2020 | 40218 | 0.070 |
Why?
|
Depression | 2 | 2024 | 8230 | 0.070 |
Why?
|
Glucocorticoids | 1 | 2017 | 2167 | 0.070 |
Why?
|
Activities of Daily Living | 1 | 2016 | 2430 | 0.070 |
Why?
|
Telemedicine | 1 | 2024 | 3109 | 0.070 |
Why?
|
Renal Dialysis | 1 | 2016 | 1791 | 0.070 |
Why?
|
Logistic Models | 4 | 2019 | 13290 | 0.070 |
Why?
|
Sepsis | 1 | 2020 | 2608 | 0.070 |
Why?
|
Pelvis | 2 | 2020 | 736 | 0.060 |
Why?
|
California | 1 | 2010 | 1438 | 0.060 |
Why?
|
Hepatorenal Syndrome | 1 | 2006 | 76 | 0.060 |
Why?
|
Incidence | 6 | 2023 | 21538 | 0.060 |
Why?
|
Appendectomy | 2 | 2022 | 444 | 0.060 |
Why?
|
Education, Medical, Graduate | 1 | 2017 | 2420 | 0.060 |
Why?
|
Inpatients | 3 | 2023 | 2566 | 0.060 |
Why?
|
Gastrointestinal Agents | 1 | 2009 | 511 | 0.060 |
Why?
|
Nursing Homes | 2 | 2023 | 1084 | 0.060 |
Why?
|
Pulmonary Embolism | 1 | 2018 | 2599 | 0.060 |
Why?
|
Severity of Illness Index | 2 | 2020 | 15948 | 0.060 |
Why?
|
Chi-Square Distribution | 1 | 2010 | 3436 | 0.060 |
Why?
|
Program Development | 2 | 2020 | 1300 | 0.060 |
Why?
|
Medicare | 1 | 2022 | 6809 | 0.060 |
Why?
|
Liver Neoplasms | 1 | 2019 | 4362 | 0.060 |
Why?
|
Health Services Accessibility | 1 | 2021 | 5520 | 0.060 |
Why?
|
Kidney Failure, Chronic | 1 | 2016 | 2496 | 0.050 |
Why?
|
Young Adult | 5 | 2021 | 60066 | 0.050 |
Why?
|
Abdomen | 1 | 2009 | 1136 | 0.050 |
Why?
|
Breast Neoplasms | 1 | 2010 | 21206 | 0.050 |
Why?
|
Matched-Pair Analysis | 1 | 2023 | 285 | 0.050 |
Why?
|
Massachusetts | 3 | 2021 | 8890 | 0.050 |
Why?
|
Lymphoproliferative Disorders | 1 | 2006 | 528 | 0.050 |
Why?
|
Analysis of Variance | 1 | 2010 | 6229 | 0.050 |
Why?
|
Cell Compartmentation | 1 | 2021 | 383 | 0.040 |
Why?
|
Phenotype | 1 | 2019 | 16726 | 0.040 |
Why?
|
Propensity Score | 2 | 2018 | 1969 | 0.040 |
Why?
|
Norepinephrine | 1 | 2023 | 898 | 0.040 |
Why?
|
Hematologic Tests | 1 | 2021 | 239 | 0.040 |
Why?
|
Intestinal Fistula | 1 | 2020 | 146 | 0.040 |
Why?
|
Postoperative Period | 1 | 2024 | 1826 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 3 | 2023 | 36743 | 0.040 |
Why?
|
Saliva | 1 | 2024 | 853 | 0.040 |
Why?
|
Pilot Projects | 2 | 2024 | 8741 | 0.040 |
Why?
|
Ileus | 1 | 2018 | 65 | 0.040 |
Why?
|
Perioperative Period | 1 | 2020 | 253 | 0.040 |
Why?
|
Parasitic Diseases | 1 | 2018 | 76 | 0.040 |
Why?
|
DNA Mismatch Repair | 1 | 2021 | 431 | 0.040 |
Why?
|
Parietal Lobe | 1 | 2023 | 866 | 0.040 |
Why?
|
Developed Countries | 1 | 2021 | 451 | 0.040 |
Why?
|
Causality | 1 | 2024 | 1254 | 0.040 |
Why?
|
Postoperative Hemorrhage | 1 | 2021 | 419 | 0.040 |
Why?
|
Marital Status | 1 | 2018 | 426 | 0.030 |
Why?
|
Chemokines | 1 | 2021 | 963 | 0.030 |
Why?
|
Longitudinal Studies | 2 | 2024 | 14783 | 0.030 |
Why?
|
Epidermis | 1 | 2019 | 539 | 0.030 |
Why?
|
Myocardial Infarction | 1 | 2017 | 11519 | 0.030 |
Why?
|
Prospective Studies | 4 | 2024 | 54926 | 0.030 |
Why?
|
Myeloid Cells | 1 | 2021 | 839 | 0.030 |
Why?
|
Adolescent | 6 | 2021 | 89169 | 0.030 |
Why?
|
Cytomegalovirus | 1 | 2021 | 753 | 0.030 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2021 | 845 | 0.030 |
Why?
|
Stromal Cells | 1 | 2021 | 1336 | 0.030 |
Why?
|
Ablation Techniques | 1 | 2018 | 255 | 0.030 |
Why?
|
Sex Factors | 2 | 2020 | 10632 | 0.030 |
Why?
|
Immunity | 1 | 2021 | 1003 | 0.030 |
Why?
|
Sex Distribution | 1 | 2020 | 2278 | 0.030 |
Why?
|
Radiography, Abdominal | 1 | 2018 | 541 | 0.030 |
Why?
|
Lung Neoplasms | 1 | 2019 | 13586 | 0.030 |
Why?
|
Forkhead Transcription Factors | 1 | 2022 | 1625 | 0.030 |
Why?
|
Muscle, Smooth | 1 | 2019 | 931 | 0.030 |
Why?
|
Clinical Trials as Topic | 1 | 2010 | 8054 | 0.030 |
Why?
|
World Health Organization | 1 | 2021 | 1329 | 0.030 |
Why?
|
Disease Progression | 2 | 2024 | 13671 | 0.030 |
Why?
|
Mass Screening | 2 | 2021 | 5458 | 0.030 |
Why?
|
Liver Transplantation | 1 | 2006 | 2401 | 0.030 |
Why?
|
Cognition | 2 | 2023 | 7073 | 0.030 |
Why?
|
Early Diagnosis | 1 | 2019 | 1194 | 0.030 |
Why?
|
Eosinophilia | 1 | 2018 | 556 | 0.030 |
Why?
|
Morbidity | 1 | 2019 | 1755 | 0.030 |
Why?
|
Smoking | 2 | 2023 | 9092 | 0.030 |
Why?
|
Aftercare | 1 | 2019 | 916 | 0.030 |
Why?
|
SEER Program | 1 | 2018 | 1444 | 0.030 |
Why?
|
Health Status Indicators | 1 | 2019 | 969 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2023 | 22291 | 0.030 |
Why?
|
Intestines | 1 | 2022 | 1909 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2020 | 2732 | 0.030 |
Why?
|
Neoplasms | 1 | 2022 | 22371 | 0.030 |
Why?
|
Pharyngeal Diseases | 1 | 1973 | 134 | 0.030 |
Why?
|
Heart Transplantation | 1 | 2006 | 3301 | 0.020 |
Why?
|
Paralysis | 1 | 1973 | 250 | 0.020 |
Why?
|
Monocytes | 1 | 2021 | 2605 | 0.020 |
Why?
|
Postoperative Care | 1 | 2018 | 1480 | 0.020 |
Why?
|
Kidney Transplantation | 1 | 2006 | 4262 | 0.020 |
Why?
|
Cost of Illness | 1 | 2021 | 1951 | 0.020 |
Why?
|
Pharynx | 1 | 1973 | 436 | 0.020 |
Why?
|
Age of Onset | 1 | 2017 | 3347 | 0.020 |
Why?
|
Recovery of Function | 1 | 2020 | 2981 | 0.020 |
Why?
|
Reference Values | 1 | 2017 | 4938 | 0.020 |
Why?
|
Overweight | 1 | 2021 | 2448 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2022 | 3948 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2022 | 11095 | 0.020 |
Why?
|
Neutrophils | 1 | 2021 | 3786 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2019 | 4912 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2021 | 3589 | 0.020 |
Why?
|
Recurrence | 1 | 2021 | 8509 | 0.020 |
Why?
|
Acute Disease | 1 | 2019 | 7243 | 0.020 |
Why?
|
Intestinal Mucosa | 1 | 2019 | 3044 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2021 | 7608 | 0.020 |
Why?
|
Deglutition Disorders | 1 | 1973 | 640 | 0.020 |
Why?
|
Carcinoma | 1 | 2019 | 2332 | 0.020 |
Why?
|
Societies, Medical | 1 | 2019 | 3968 | 0.020 |
Why?
|
Genotype | 1 | 2022 | 13045 | 0.020 |
Why?
|
Genetic Testing | 1 | 2019 | 3591 | 0.020 |
Why?
|
Alcoholism | 1 | 2017 | 1980 | 0.020 |
Why?
|
Tuberculosis | 1 | 2018 | 2029 | 0.020 |
Why?
|
Child, Preschool | 3 | 2020 | 42669 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2021 | 8647 | 0.020 |
Why?
|
Body Mass Index | 1 | 2023 | 13053 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2021 | 17140 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2020 | 6669 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2021 | 10266 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2018 | 13014 | 0.010 |
Why?
|
Graft Rejection | 2 | 2006 | 4492 | 0.010 |
Why?
|
Emergency Medical Services | 1 | 2014 | 1947 | 0.010 |
Why?
|
Diet | 1 | 2021 | 8089 | 0.010 |
Why?
|
Inflammation | 1 | 2021 | 10873 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2019 | 7454 | 0.010 |
Why?
|
Child | 3 | 2020 | 80917 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 11878 | 0.010 |
Why?
|
Graft Survival | 1 | 2006 | 3887 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2018 | 20760 | 0.010 |
Why?
|
Mutation | 1 | 2019 | 30238 | 0.010 |
Why?
|
Obesity | 1 | 2017 | 13090 | 0.010 |
Why?
|
Lateral Medullary Syndrome | 1 | 1973 | 9 | 0.010 |
Why?
|
Infant | 2 | 2006 | 36535 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2017 | 12252 | 0.010 |
Why?
|
Brain | 1 | 2020 | 27360 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 2006 | 4206 | 0.010 |
Why?
|
Prevalence | 1 | 2006 | 15869 | 0.000 |
Why?
|
Music | 1 | 1971 | 247 | 0.000 |
Why?
|
Voice | 1 | 1971 | 268 | 0.000 |
Why?
|
Infant, Newborn | 1 | 2006 | 26422 | 0.000 |
Why?
|
Voice Training | 1 | 1971 | 44 | 0.000 |
Why?
|
Vocal Cords | 1 | 1971 | 520 | 0.000 |
Why?
|
Larynx | 1 | 1971 | 492 | 0.000 |
Why?
|
Muscles | 1 | 1971 | 1582 | 0.000 |
Why?
|
Electromyography | 1 | 1971 | 1401 | 0.000 |
Why?
|
Respiration | 1 | 1971 | 1665 | 0.000 |
Why?
|
Concepts
(298)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(77)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_